While the mechanisms of tumor cell resistance are well understood, it remains unclear whether CSF1R inhibition alters the overall composition and dynamics of the GBM TME, and whether similar effects are observed in other types of brain tumors. The gene discussed is CSF1R; the disease is neoplasm.